Nanotechnology Startups

Helix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.

13 investors

Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.

6 investors

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

5 investors

Arylla produces invisible ink tags using nanotechnology that can be applied to fashion products and read via smartphone to enable authentication, traceability, and personalized customer experiences. The tags integrate with third-party platforms like WeChat and WhatsApp to connect consumers with branded content and product verification.

3 investors

Kern Systems develops a cold data storage platform using synthetic DNA molecules and enzymes to archive data with superior density, durability, and energy efficiency compared to traditional storage technologies. The platform targets the growing market for long-term archival storage of rarely-accessed unstructured data.

2 investors

spotLESS Materials develops nature-inspired liquid-entrenched smooth surface (LESS) coatings that repel liquids, sludge, and contaminants while enabling self-cleaning properties for industrial applications including sanitation, automotive, and medical sectors.

2 investors

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

1 investor

Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.

1 investor

Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.

1 investor

Silver manufactures a portable Raman spectroscope device that uses specialized nanoparticle technology to help consumers quickly identify contaminants in their environment or products.

1 investor